A preclinical survey on the efficacy of lactandrate in the treatment of colon carcinoma

Journal of B.U.ON.

Volumn 10, Issue 2, 2005, Pages 227-234

  Trafalis, Dimitrios T P ^a,e   Geromichalos, G D ^b   Bountouroglou, N ^a   Koumbi, D ^c   Kontos, M ^c   Sougias, D ^a   Dalezis, P ^b   Karamanakos, P ^c   Papageorgiou, A ^b   Camoutsis, C ^d   Athanassiou, A E ^a  

^a METAXA CANCER HOSPITAL   (Greece)

^b THEAGENIO CANCER HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d UNIVERSITY OF PATRAS   (Greece)

^e NONE   (Greece)

Author keywords

Colon carcinoma; Homo aza steroids; Human cell lines; In vitro; In vivo; Lactam steroid alkylator

Indexed keywords

ANDROSTERONE DERIVATIVE; ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; LACTANDRATE; SULFORHODAMINE B; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCULATION; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RESEARCH; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; COLON ADENOCARCINOMA; COLORIMETRY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSTASIS; CYTOTOXICITY; DRUG EFFICACY; DRUG MECHANISM; DRUG STRUCTURE; GROWTH INHIBITION; HEALTH SURVEY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; NONHUMAN; PROTEIN SYNTHESIS; RODENT; STRUCTURE ANALYSIS;

EID: 24944497545     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Boring CC, Squires TS, Tang T, Montgomery S. Cancer statistics. CA Cancer J Clin 1994; 44: 7-26.
2. Gatta G, Ciccolallo L, Capocaccia R et al. Differences in colorectal cancer survival between European and US populations: the importance of sub-site and morphology. Eur J Cancer 2003; 39: 2214-2222.
3. ESMO. Minimum Clinical Recommendations for diagnosis, adjuvant treatment and follow-up of colon cancer. Ann Oncol 2005; 16 (Suppl 1): i16-i17.
4. Wilkes GM.Therapeutic options in the management of colon cancer: 2005 update. Clin J Oncol Nurs 2005; 9: 31-44.
5. Venook A. Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 2005; 10: 250-261.
6. Haller DG. Recent updates in the clinical use of platinum compounds for the treatment of gastrointestinal cancers. Semin Oncol 2004; 31(6 Suppl 14): 10-16.
7. Camoutsis C, Trafalis DTP. An overview on the antileukemic potential of D-homo-aza- and respective 17β-acetamidosteroidal alkylating esters. Invest New Drugs 2003; 21: 47-54.
8. Catsoulacos P, Catsoulacos D. Conjugated systems of homoaza-steroidal esters in cancer chemotherapy. Anticancer Res 1994; 14: 2525-2528.
9. Trafalis DTP, Camoutsis C, Dalezis P et al. Antitumour effect of A- and D- lactam androgen nitrogen mustards on non-small cell lung carcinoma. J BUON 2004; 9: 75-82.
10. Catsoulacos P, Boutis L. Aza-steroids. Beckmann rearrangement of 3β-acetoxy-5α-androstan-17-one oxime acetate with boron fluoride. Alkylating agents. Chim Ther 1973; 8: 215-217.
11. Skehan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer drug screening. J Natl Cancer Inst 1990; 82: 1107-1112.
12. Principles of laboratory animal care. NIH publication 1985; No 85: 23.
13. Catsoulacos P, Politis D, Wampler GL. A new steroidal alkylating agent with improved activity in advanced murine leukemias. Cancer Chemother Pharmacol 1979; 3: 67-70.
14. Catsoulacos P, Camoutsis C, Wampler GL. Effect of a D5-homo-aza-steroidal ester in P388 and L1210 murine leukemias. Oncology 1982; 39: 59-60.
15. Catsoulacos P. Activity of 3b-hydroxy-13a-amino-13, 17-seco-5a-androstan-17-oic-13,17-lactam p-bis(2-chloroethyl)aminophenoxy acetate (NSC-294859) on experimental tumor and leukemia systems. Oncology 1983; 40: 290-292.
16. Catsoulacos P, Wampler GL. Activity of 3b-hydroxy-13a-amino-13, 17-seco-5a-androstan-17-oic-13, 17-lactam(p-bis(2-chloroethyl)amino)-phenylacetate (NSC-290205) in murine solid tumors. Oncology 1982; 39: 109-112.
17. Catsoulacos P. Further studies on the anti-neoplastic activity of 3b-hydroxy-13a-amino-13, 17-seco-5a-androstan-17-oic-13, 17-lactam(p-bis(2-chloroethyl)amino)-phenylacetate(NSC-290205). Cancer Lett 1984; 22: 199-202.
18. Wall ME, Abernethy SG, Carroll JFI, Taylor DJ. The effects of some steroidal alkylating agents on experimental animal mammary tumor and leukemia systems. J Med Chem 1969; 12: 810-818.
19. Wampler GL, Catsoulacos P. Antileukemic effect of homoaza-steroidal-ester of p-[bis(2-chloroethyl)amino]acetic acid. Cancer Treat Rep 1977; 61: 37-41.
20. Kabara JJ, Holzschu DL, Catsoulacos P. Structure, function, activity of azasterols and nitrogen containing steroids. Lipids 1976; 11: 7555-7562.
21. Ma D, Wamg G, Wang S, Kozikowski AP, Lewin NE, Blumberg PM. Synthesis and protein kinase C binding activity of benzolactam-V-7. Bioorg Med Chem Lett 1999; 9: 1371-1374.
22. Endo Y, Yokohama A. Role of the hydrophobic moiety of tumor promoters. Synthesis and activity of 2-alkylated benzolactams. Bioorg Med Chem Lett 2000; 10: 63-66.
23. Endo Y, Shimazu M, Fukasawa H et al. Synthesis, computer modeling and biological evaluation of novel protein kinase C agonists based on a 7-membered lactam moiety. Bioorg Med Chem Lett 1999; 9: 173-178.
24. Catsoulacos P, Politis D, Wampler GL. Antitumor activity of homo-aza-steroidal esters of [p-bis(2-chloroethyl) amino]phenyl acetic acid and [p-bis(2-chloroethyl) amino]phenyl butyric acid. Cancer Chemother Pharmacol 1983; 10: 129-132.
25. Catsoulacos P, Catsoulacos D. Antitumor activity of homoaza-steroidal esters of p-N,N-bis(2-chloroethyl)amino phenoxy acetic acid. Anticancer Res 1993; 13: 1203-1208.
26. Catsoulacos P, Camoutsis C, PapageorgiouA, Adamiak-Margariti E. Cytostatic effect of homo-aza-steroidal esters in vivo and in vitro: structure-activity relationships. Anticancer Res 1992; 12: 1617-1620.
27. Dalmases P, Gomez-Belinchon JI, Bonet JJ, Giner-Sorolla A, Schmid FA. Antineoplastic agents. II. A nitrogen mustard derivative of N-methylated steroidal lactam. Eur J Med Chem 1983; 18: 541-543.
28. Dalmases P, Cervantes G, Quintana J, Bonet JJ. Antineoplastic agents. V. Nitrogen mustards of systematically modified steroidal ring A lactams. Eur J Med Chem 1984; 19: 465-467.
29. Papageorgiou A, Ivanov IG, Markov GG, Koliais SI, Boutis L, Catsoulacos P. Interaction of homo-aza-steroidal ester of p-[bis-(2-chloroethyl)amino] acetic acid (ASE) with DNA of Ehrlich ascites tumor cells. FEBS Lett 1983; 153: 194-198.
30. Shepherd RE, Huff K, McGuire WL. Brief communication: Estrogen receptor interaction with antitumor agent estradiol mustard. J Natl Cancer Inst 1974; 53: 895-897.
31. Camoutsis C, Trafalis DTP. An overview on the antileukemic potential of D-homo-aza- and respective 17b-acetamido-steroidal alkylating esters. Invest New Drugs 2003; 21: 47-54.
32. Catsoulacos P, Catsoulacos D. Conjugated systems of homo-aza-steroidal esters in cancer chemotherapy. Anticancer Res 1994; 14: 2525-2528.
33. Catsoulacos P, Catsoulacos D. Hybrid anticancer compounds. Steroidal lactam esters of carboxylic derivative of N,N-bis(2-chloroethyl)ani line. Anticancer Res 1991; 11: 1773-1778.
34. Aviram R, Deutsch A, Patya M et al. Biochemical tissue markers of human colorectal carcinoma. Dis Colon Rectum 1988; 31: 176-180.
35. Lorenzi M, Vindigni C, Minacci C et al. Histopathological and prognostic evaluation of immunohistochemical findings in colorectal cancer. Int J Biol Markers 1997; 12: 68-74.
36. Wagner HE, Toth CA, Steele GD Jr, Thomas P. Metastatic potential of human colon cancer cell lines: relationship to cellular differentiation and carcinoembryonic antigen production. Clin Exp Metastasis 1992; 10: 25-31.
37. Goldin A, Venditti JM. Progress report on the screening program at the Division of Cancer Treatment, National Cancer Institute. Cancer Treat Rev 1980; 7: 167-176.
38. Opolski A, Laskowska A, Madej J et al. Metastatic potential of human CX-1 colon adenocarcinoma cells is dependent on the expression of sialosyl antigen. Clin Exp Metastasis 1998; 16: 673-681.
39. Jessup JM, Petrick AT, Toth CA et al. Carcinoembryonic antigen: enhancement of liver colonization through retention of human colorectal carcinoma cells. Br J Cancer 1993; 67: 464-470.
40. Qiu Y, Langman MJ, Eggo MC. Targets of 17beta-oestradiol-induced apoptosis in colon cancer cells: a mechanism for the protective effects of hormone replacement therapy? J Endocrinol 2004; 181: 327-337.
41. Izbicki JR, Wambach G, Hamilton SR et al. Androgen receptors in experimentally induced colon carcinogenesis. J Cancer Res Clin Oncol 1986; 112: 39-46.
42. Catalano MG, Pfeffer U, Raineri M et al. Altered expression of androgen receptor isoforms in human colon cancer tissues. Int J Cancer 2000; 86: 325-330.Ss